BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q4FY23 Financial Results22-05-2023
22-05-2023
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copy of newspaper advertisement of the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 published in Business Standard (in English) and Tarun Bharat (in Marathi).22-05-2023
Q4FY23 Quarterly & FY23 Annual Result Announced for Balaji Amines Ltd.
Specialty Chemicals company Balaji Amines announced Q4FY23 & FY23 results: Consolidated Q4FY23: Revenue from Operations for Q4FY23 stood at Rs 476.90 crore, as compared to Rs 785.41 crore in Q4FY22. Total volumes stood at 26,505 MT for Q4FY23 as against 33,780 MT in Q4FY22. For Q4FY23, Amines volumes stood at 6,659 MT Amines Derivatives volumes stood at 8,607 MT Specialty Chemicals volumes stood at 11,239 MT EBITDA for Q4FY23 was Rs 98.63 crore, as compared to Rs 201.16 crore in Q4FY22. EBITDA margin for Q4FY23 stood at 20.68% as against 25.61% in Q4FY22. The fall in operating margin was primarily on account of degrowth in the pharma and API sector. PAT for Q4FY23 was Rs 55.21 crore, as compared to Rs 130.85 crore in Q4FY22. Diluted EPS for Q4FY23 stood at Rs 14.63 per equity share as against Rs 33.56 in Q4FY22. Consolidated FY23: Revenue from Operations for FY23 stood at Rs 2,370.64 crore, as compared to Rs 2,337.60 crore in FY22. Total volumes stood at 1,10,508 MT for FY23 as against 1,15,349 MT in FY22. For FY23, Amines volumes stood at 25,789 MT Amines Derivatives volumes stood at 33,091 MT Specialty Chemicals volumes stood at 51,628 MT EBITDA for FY23 was Rs 624.36 crore, as compared to Rs 637.39 crore in FY22. EBITDA margin for FY23 stood at 26.34% as against 27.27% in FY22. The fall in operating margin was primarily on account of degrowth in the pharma and API sector. PAT for FY23 was Rs 405.68 crore, as compared to Rs 417.90 crore in FY22. Diluted EPS for FY23 stood at Rs 100.47 per equity share as against Rs 113.71 in FY22. On the performance, D. Ram Reddy, Managing Director, commented, "Despite headwinds in pharma API and Agro industries globally, we have delivered decent results. The fall in the margins was primarily on account of degrowth in Pharma API and Agro sector. We believe the performance of the company will improve gradually in the coming months, we anticipate a return to growth & margin levels similar to those achieved before the onset of the COVID-19 pandemic in due course, which we think is sustainable. In the past years, we experienced exceptionally high realizations for certain products, driven by global circumstances that have since normalized. Our capex that we had planned was based on the normalized profitability and hence our company will not be impacted adversely by it. In fact, we maintain a positive outlook on the sector and firmly believe in prioritizing growth. We are confident that the products we manufacture have significant demand within India and can effectively substitute imported alternatives. Revenues from the new commenced plants such as DMC, PG, Ethylamines will start contributing to our top line from coming quarters, which in turn can improve the margin profile of the company from Q1FY24. In the long term we are confident of creating sustainable value for the stakeholders." Result PDF22-05-2023
Dismal Q4 earnings drag Balaji Amines shares to 52-week low
Balaji Amines' Q4 numbers disappointed the Streets on the all three fronts of profit, revenue and profitability.22-05-2023
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release in connection with Audited Financial Results for the Quarter and Year ended 31st March, 202321-05-2023
BALAJI AMINES LTD.-$ - 530999 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 relating to Resignation of Mr. Hemanth Reddy Gaddam as Whole-time Director and Chief Financial Officer (CFO) with effect from closing hours on 20th May, 2023.21-05-2023
BALAJI AMINES LTD.-$ - 530999 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure of Related Party Transactions for the Half Year ended 31st March, 2023.20-05-2023
BALAJI AMINES LTD.-$ - 530999 - Announcement Under Regulation 30 (LODR) - Intimation Of Change In Designation Of Directors
Intimation of Change in Designation of Directors20-05-2023
BALAJI AMINES LTD.-$ - 530999 - Announcement Under Regulation 30 (LODR) - Intimation Of Appointment Of Independent Directors
Intimation of Appointment of Independent Directors20-05-2023